Artículos por temáticas

Clinical diagnostic criteria and classification controversies in frontotemporal lobar degeneration

Rascovsky K, Grossman M.

Int Rev Psychiatry. 2013 Apr;25(2):145-58. doi: 10.3109/09540261.2013.763341.

Detection of mild cognitive impairment and early stage dementia with an audio-recorded cognitive scale

Sewell MC, Luo X, Neugroschl J, Sano M.

Int Psychogeriatr. 2013 Aug;25(8):1325-33. doi: 10.1017/S1041610213000598. Epub 2013 May 2.

Challenges in assessing nursing home residents with advanced dementia for suspected urinary tract infections

D'Agata E, Loeb MB, Mitchell SL.

J Am Geriatr Soc. 2013 Jan;61(1):62-6. doi: 10.1111/jgs.12070.

Mild cognitive impairment due to Alzheimer disease in the community

Petersen RC, Aisen P, Boeve BF, Geda YE, Ivnik RJ, Knopman DS, Mielke M, Pankratz VS, Roberts R, Rocca WA, Weigand S, Weiner M, Wiste H, Jack CR Jr.

Ann Neurol. 2013 Aug;74(2):199-208. doi: 10.1002/ana.23931.

Ushering in the study and treatment of preclinical Alzheimer disease

Langbaum JB, Fleisher AS, Chen K, Ayutyanont N, Lopera F, Quiroz YT, Caselli RJ, Tariot PN, Reiman EM.

Nat Rev Neurol. 2013 Jul;9(7):371-81. doi: 10.1038/nrneurol.2013.107. Epub 2013 Jun 11.

Military risk factors for Alzheimer's disease

Weiner MW, Friedl KE, Pacifico A, Chapman JC, Jaffee MS, Little DM, Manley GT, McKee A, Petersen RC, Pitman RK, Yaffe K, Zetterberg H, Obana R, Bain LJ, Carrillo MC.

Alzheimers Dement. 2013 Jul;9(4):445-51. doi: 10.1016/j.jalz.2013.03.005.

From forgetfulness to dementia: clinical and commissioning implications of diagnostic experiences

Manthorpe J, Samsi K, Campbell S, Abley C, Keady J, Bond J, Watts S, Robinson L, Warner J, Iliffe S.

Br J Gen Pract. 2013 Jan;63(606):e69-75. doi: 10.3399/bjgp13X660805.

Nutrition and neurodegeneration: epidemiological evidence and challenges for future research

Gillette-Guyonnet S, Secher M, Vellas B.

Br J Clin Pharmacol. 2013 Mar;75(3):738-55. doi: 10.1111/bcp.12058.

Randomized controlled trial of mibampator for behavioral and psychological symptoms of dementia: comments on the trial and thoughts for future studies

Ballard C, Francis P, Corbett A.

Int Psychogeriatr. 2013 May;25(5):687-9. doi: 10.1017/S1041610213000033. Epub 2013 Jan 25.

Alzheimer disease biomarkers and insights into mild cognitive impairment

Knopman DS.

Neurology. 2013 Mar 12;80(11):978-80. doi: 10.1212/WNL.0b013e31828728ac. Epub 2013 Feb 6.

Frontotemporal dementia in eight Chinese individuals

Chao SZ, Rosen HJ, Azor V, Ong H, Tse MM, Lai NB, Hou CE, Seeley WW, Miller BL, Matthews BR.

Neurocase. 2013;19(1):76-84. doi: 10.1080/13554794.2011.654218. Epub 2012 Jun 14.

A 12-week multidomain intervention versus active control to reduce risk of Alzheimer's disease: study protocol for a randomized controlled trial

Anstey KJ, Bahar-Fuchs A, Herath P, Rebok GW, Cherbuin N.

Trials. 2013 Feb 27;14:60. doi: 10.1186/1745-6215-14-60.

Neuropsychiatric and parkinsonian manifestations of dementia: a case report in a Nigerian woman

Adebayo PB, Ajani AA, Adeniji OA, Akinyemi RO.

Ann Afr Med. 2013 Jan-Mar;12(1):46-8. doi: 10.4103/1596-3519.108252.

Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study

Pedersen KF, Larsen JP, Tysnes OB, Alves G.

JAMA Neurol. 2013 May;70(5):580-6. doi: 10.1001/jamaneurol.2013.2110.

"Will I get Alzheimer disease?" when cognitively normal patients ask to be tested for Alzheimer disease

Snider BJ, Buckles VD.

Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):470-4. doi: 10.1212/01.CON.0000429171.50686.07.